戻る Agenda
Session 2 Track 3: Life Going Virtual
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
Kevin Appareti
Senior Director, Global Medical Science Liaison
Royal Philips, United States
While virtual HCP interactions are not novel, the effects of the COVID-19 pandemic have forced medical science liaison and medical affairs professionals to quickly pivot exclusively to these virtual interactions. With this pivot, new opportunities have been realized and challenges addressed to ensure continuous and open connections with the HCP community. This session will review these opportunities and challenges, share principles of effective virtual engagement, and provide examples of unique innovation for MSLs and medical affairs personnel to apply while working in a virtual environment.
Learning Objective : - Discuss the challenges and benefits of virtual HCP interactions
- Review Principles of Effective Virtual Engagement (Etiquette, Expectations, Clarity of Objectives, Follow-up, etc.)
- Discuss examples of innovation within Medical Affairs and Medical Science Liaison roles during a pandemic
- Describe how the loss of boundaries can expand internal and external engagements while removing geographical limits
Speaker(s)
Speaker
Sarah Jarvis, MBA
ZS, United States
Global Medical Affairs Lead
Speaker
Debbie Yen, PharmD
Sanofi, United States
Medical Science Liaison, Cardiovascular
Speaker
Kevin Appareti
Royal Philips, United States
Senior Director, Global Medical Science Liaison